Figure 1 | Scientific Reports

Figure 1

From: SLC39A4 expression is associated with enhanced cell migration, cisplatin resistance, and poor survival in non-small cell lung cancer

Figure 1

SLC39A4 is an independent predictor of non-small cell lung cancer (NSCLC). (a) Meta-analysis of SLC39A4 expression in NSCLC samples and normal tissues. Mean differences were estimated using an inverse variance (IV)-weighted random-effects model (Mean difference, 1.48; 95% CI, 0.88–2.08). (b) Meta-analysis of SLC39A4 specificity and sensitivity as a biomarker of NSCLC. (c) SLC39A4 expression association with tumour stage using a Mantel-Haenszel (M-H)-weighted random-effects model (Odds Ratio [OR], 0.52; 95% CI, 0.34–0.80).

Back to article page